Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
This drug became the worlds first approved non-peptide oral small-molecule GLP-1 receptor agonist , marking a major milestone in the transition of the GLP-1 therapeutic field toward small-molecule innovation
Additionally, the favorable persistence and adherence are likely to contribute to improved clinical outcomes
Amin, H., Arain, B
Do not rush the titration schedule
LAC (or placebo) was started intramuscularly at a dosage of 1000 mg/day for 10 days and continued orally at a dosage of 2000 mg/day for the remainder of the study (355 days)
US$ 24.70
US$ 20.02
US$ 22.51
US$ 22.71
US$ 28.77
US$ 28.23
US$ 25.41
US$ 26.62
US$ 21.57
